Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pulmonary function and survival one year after dupilumab treatment of acute moderate to severe COVID-19: A follow up study from a Phase IIa trial

medRxiv(2023)10.1101/2023.09.01.23293947Source: DataRank Database

Pulmonary function and survival one year after dupilumab treatment of acute moderate to severe COVID-19: A follow up study from a Phase IIa trial is a research paper published in medRxiv (2023). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)OA: greenTopics (16)IDs (PubMed, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Jennie Z. Ma ORCID,Heather M. Haughey,Rachael Coleman,Uma Nayak ORCID,Alexandra Kadl ORCID

Live enrichment

PubMed:37693596 OpenAlex:https://openalex.org/W4386401009

Wellcome Trust

Grant: 106898/A/15/Z

National Institutes of Health

Grant: 2R01AI124214-06

Role of Type 2 Immunity in Innate Protection from C. difficile

Wellcome Trust

Grant: 106898

Chitinase-like proteins: Host protection through molecular multi-tasking.

National Institutes of Health

Grant: 3UL1TR003015-03S1

The integrated Translational Health Research Institute of Virginia (iTHRIV): Using Data to Improve Health

National Institutes of Health

Grant: 5TL1DK132771-05

IGNITE KUH NRSA Training Core

UK Research and Innovation

Grant: MR/V011235/1

Myeloid cells in type 2 immunity: unravelling susceptibility and resistance to tissue nematode infection

National Institutes of Health

Grant: 3T32DK072922-08S1

Kidney Disease and Inflammation

National Institutes of Health

Grant: 1KL2TR003016-01

Institutional Career Development Core

NCATS NIH HHS

Grant: KL2 TR003016

NIAID NIH HHS

Grant: R01 AI124214

NIDDK NIH HHS

Grant: TL1 DK132771

NCATS NIH HHS

Grant: UL1 TR003015

Wellcome Trust

greenLicense: cc-by-nd

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2023/09/02/2023.09.01.23293947.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.09.01.23293947

repositoryhttps://doi.org/10.1101/2023.09.01.23293947

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37693596

Fields of Study

Long-Term Effects of COVID-19COVID-19 Clinical Research StudiesCancer Immunotherapy and Biomarkers

Keywords

Coronavirus disease 2019 (COVID-19)DupilumabMedicine2019-20 coronavirus outbreakPulmonary function testingSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Internal medicineClinical trialOncologyVirologyOutbreakDiseaseArticle

Sustainable Development Goals

SDG 0: Good health and well-being